» Articles » PMID: 34174588

Altered Expression of SARS-CoV-2 Entry and Processing Genes by Porphyromonas Gingivalis-derived Lipopolysaccharide, Inflammatory Cytokines and Prostaglandin E in Human Gingival Fibroblasts

Overview
Journal Arch Oral Biol
Specialty Dentistry
Date 2021 Jun 26
PMID 34174588
Citations 14
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: The aim of this in vitro study was to investigate the expression of SARS-CoV-2 entry and processing genes in human gingival fibroblasts (HGnF) following treatment with Porphyromonas gingivalis-derived lipopolysaccharide (PgLPS) or inflammatory cytokines/mediators.

Design: We assessed the expression of SARS-CoV-2 entry and processing genes; angiotensin-converting enzyme 2 (ACE2), cellular serine proteases transmembrane serine protease 2 (TMPRSS2), Furin, and basigin (BSG) in HGnF by real-time PCR. To further asses the contribution of PgLPS and inflammatory cytokines/mediators to proliferation and SARS-CoV-2 entry and processing gene expression, HGnF were treated with PgLPS, IL1β, TNFα, and PGE.

Results: The expression for ACE2 in HGnF was significantly elevated after PgLPS or IL1β, TNFα, PGE treatment. The expression of TMPRSS2 was increased by PgLPS, IL1β, or PGE while BSG was elevated by PgLPS and IL1β. The expression of BSG and FURIN decreased after TNFα treatment.

Conclusion: SARS-CoV-2 entry and processing genes are expressed in human gingival fibroblasts and their expressions are altered by PgLPS, IL1β, TNFα and PGE treatment.

Citing Articles

The presence of ACE2 and regulatory miRNAs (miR-200c-3p and miR-421-5p) in the saliva of periodontitis patients post-COVID-19 vaccination.

Bachtiar B, Haerani N, Soeroso Y, Ismah N, Bachtiar E Front Dent Med. 2025; 5:1438139.

PMID: 39917640 PMC: 11797934. DOI: 10.3389/fdmed.2024.1438139.


Pathogenic and periodontal bacteria may contribute to the fatal outcome of critically ill elderly COVID-19 patients.

Madronero L, Calvo E, Coronel-Ruiz C, Velandia-Romero M, Calderon-Pelaez M, Arturo J Sci Rep. 2025; 15(1):4490.

PMID: 39915668 PMC: 11802917. DOI: 10.1038/s41598-025-88518-y.


Inhibition of SARS-CoV-2 infection by and the oral microbiome.

Bontempo A, Chirino A, Heidari A, Lugo A, Shindo S, Pastore M Microbiol Spectr. 2024; 12(10):e0059924.

PMID: 39162507 PMC: 11448423. DOI: 10.1128/spectrum.00599-24.


Identification of receptors and factors associated with human coronaviruses in the oral cavity using single-cell RNA sequencing.

Gao F, Lin W, Wang X, Liao M, Zhang M, Qin N Heliyon. 2024; 10(7):e28280.

PMID: 38560173 PMC: 10981076. DOI: 10.1016/j.heliyon.2024.e28280.


Association between dysbiotic perio-pathogens and inflammatory initiators and mediators in COVID-19 patients with diabetes.

Bachtiar E, Bachtiar B, Kusumaningrum A, Sunarto H, Soeroso Y, Sulijaya B Heliyon. 2024; 10(2):e24089.

PMID: 38293542 PMC: 10825424. DOI: 10.1016/j.heliyon.2024.e24089.


References
1.
Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J . Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China. JAMA. 2020; 323(11):1061-1069. PMC: 7042881. DOI: 10.1001/jama.2020.1585. View

2.
Walls A, Park Y, Tortorici M, Wall A, McGuire A, Veesler D . Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein. Cell. 2020; 181(2):281-292.e6. PMC: 7102599. DOI: 10.1016/j.cell.2020.02.058. View

3.
Li Y, Zhou W, Yang L, You R . Physiological and pathological regulation of ACE2, the SARS-CoV-2 receptor. Pharmacol Res. 2020; 157:104833. PMC: 7194807. DOI: 10.1016/j.phrs.2020.104833. View

4.
Halboub E, Al-Maweri S, Alanazi R, Qaid N, Abdulrab S . Orofacial manifestations of COVID-19: a brief review of the published literature. Braz Oral Res. 2020; 34:e124. DOI: 10.1590/1807-3107bor-2020.vol34.0124. View

5.
La Rosa G, Libra M, De Pasquale R, Ferlito S, Pedulla E . Association of Viral Infections With Oral Cavity Lesions: Role of SARS-CoV-2 Infection. Front Med (Lausanne). 2021; 7:571214. PMC: 7840611. DOI: 10.3389/fmed.2020.571214. View